GO enrichment analysis of DEPs.

GO enrichment analysis of DEPs.

<p><b>(A)</b> GO analysis of upregulated DEPs. <b>(B)</b> GO analysis of downregulated DEPs.</p>

Збережено в:

Бібліографічні деталі
Автор:	Jing Liu (38537) (author)
Інші автори:	Junshuang Wang (22683435) (author), Shuang Lv (660117) (author), Hengjiao Wang (21539904) (author), Defu Yang (735577) (author), Ying Zhang (40767) (author), Ying Li (38224) (author), Huiling Qu (6104225) (author), Ying Xu (9172) (author), Ying Yan (47692) (author)
Опубліковано:	2025
Предмети:	Biophysics Biochemistry Medicine Cell Biology Genetics Molecular Biology Neuroscience Pharmacology Evolutionary Biology Cancer Mental Health Infectious Diseases Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified tandem mass tagging resolution mass spectrometry 30 gy ). induced brain injury ribi &# 8217 ppi network analysis key hub protein kegg analysis highlighted identifying key proteins xlink "> radiation identify potential biomarkers xlink "> potential biomarkers potential role brain tumors brain tissues brain tissue brain irradiation tight junctions therapeutic targets targeted therapies study aims ribi pathophysiology rat model protein interaction ppar signaling pathways related pathways involved pathway analyses neurological impairments neurocognitive deficits molecular pathology molecular mechanisms mitigate radiation metabolic processes mainly involved lipid transport kyoto encyclopedia irradiated rats increased expression gene ontology findings suggest could serve clinical intervention cell adhesion biological processes associated pathways
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси

GO analysis of downregulated DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

GO analysis of upregulated DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

PPI network analysis of DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

KEGG enrichment analysis of DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

KEGG analysis of downregulated DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

KEGG analysis of upregulated DEPs.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

DEPs based on subcellular localization.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

DEPs based on structural domains.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Classification of DEPs based on structural domains and subcellular localization.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Volcano plot and heatmap of DEPs between RIBI and control tissues.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Immunohistochemical staining for PHLDA3, APOE, and CPE in irradiated brain tissues.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Principal component analysis and repeatability analysis.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Representative HE staining images of brain tissues.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Differentially expressed proteins.
за авторством: Jing Liu (38537)
Опубліковано: (2025)

Fluvastatin inhibits the migration of melanoma A375 cells in a wound healing assay.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Discovery of therapeutic compounds targeting brain metastasis-associated tumor cells (MBMATCs) in high MBM-Index melanoma.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

The MBM-Index as an independent predictor of overall survival (OS) in melanoma.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Identification of melanoma brain metastasis-associated tumor cell subpopulations (MBMATCs).
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Tumor cell-specific transcriptomic features across PTs, ECMs and MBMs.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Immune landscape and CD8<sup>+</sup> T cell transition states in PTs, ECMs and MBMs.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Single cell RNA-seq and snRNA-seq profiling of the PTs (primary melanoma), ECMs (extracranial melanoma metastases) and MBMs (melanoma brain metastases) environments.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Samples & cell type composition in melanoma tumor cells.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Marker genes in melanoma tumor cells across PT, ECM and MBM by sc/snRNA-seq.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

AXL and MITF signature genes.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Samples & cell type composition in sc/snRNA-seq.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Identification of therapeutic drugs with high drug sensitivity for brain metastasis-associated tumor cells (MBMATCs) and high-brain metastasis (MBM) index patients.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

The enriched pathway by all transcripts differentially expressed between MBMATCs and other tumor cells, and between MBM-High and MBM-Low groups.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

The MBM-Index showed no significant correlation with clinicopathological features.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Interaction between MBMATCs and the immune microenvironment.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Pseudotime trajectory analysis of melanoma clusters Mela4 and Mela5.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Immune cells profiling in PTs, ECMs and MBMs.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

scRNA-seq and snRNA-seq profiling of 26 melanoma samples.
за авторством: Jingxin Zeng (18773484)
Опубліковано: (2025)

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
за авторством: Rumani Singh (17141575)
Опубліковано: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
за авторством: Marwa Zafarullah (12527002)
Опубліковано: (2025)

Statistical comparison (<i>p</i>-values) of Lempel-Ziv complexity (LZC) and Permutation Entropy (PE), for low frequency components of the signal across sleep states within each condition.
за авторством: Magaly Catanzariti (20865500)
Опубліковано: (2025)

Cannot write session to /tmp/vufind_sessions/sess_an5pio6916h0qsi0jv5j3762c3